VETERINARY DEXTROSE AND SODIUM CHLORIDE- dextrose and sodium chloride injection, solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK), SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698)

Available from:

Zoetis Inc.

Administration route:

INTRAVENOUS

Prescription type:

PRESCRIPTION

Therapeutic indications:

2.5% Dextrose and 0.45% Sodium Chloride Injection, USP is indicated as a source of water, electrolytes, and calories. Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

Product summary:

2.5% Dextrose and 0.45% Sodium Chloride Injection, USP in plastic container is supplied as follows:     Size (mL)     Code                   1000             2B8224          Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C/77°F); brief exposure up to 40°C/104°F does not adversely affect the product.

Authorization status:

unapproved drug other

Summary of Product characteristics

VETERINARY DEXTROSE AND SODIUM CHLORIDE- DEXTROSE AND SODIUM
CHLORIDE INJECTION, SOLUTION
ZOETIS INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
VETERINARY 2.5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION, USP
For Animal Use Only
DES CRIPTION
2.5% Dextrose and 0.45% Sodium Chloride Injection, USP is a sterile,
nonpyrogenic solution for fluid
and electrolyte replenishment and caloric supply in single dose
containers for intravenous
administration. It contains no antimicrobial agents. Discard unused
portion. Composition, osmolarity, pH,
concentration and caloric content are shown in Table 1.
The plastic container is fabricated from a specially formulated
polyvinyl chloride. The amount of water
that can permeate from inside the container into the overwrap is
insufficient to affect the solution
significantly. Solutions in contact with the plastic container can
leach out certain of its chemical
components in very small amounts within the expiration period, e.g.,
di-2-ethylhexyl phthalate (DEHP),
up to 5 parts per million. However, the safety of the plastic has been
confirmed in tests in animals
according to USP biological tests for plastic containers as well as by
tissue culture toxicity studies.
CLINICAL PHARMACOLOGY
2.5% Dextrose and 0.45% Sodium Chloride Injection, USP has value as a
source of water, electrolytes,
and calories. It is capable of inducing diuresis depending on the
clinical condition of the patient.
INDICATIONS AND USAGE
2.5% Dextrose and 0.45% Sodium Chloride Injection, USP is indicated as
a source of water,
electrolytes, and calories.
CONTRAINDICATIONS
Solutions containing dextrose may be contraindicated in patients with
known allergy to corn or corn
products.
WARNINGS
2.5% Dextrose and 0.45% Sodium Chloride Injection, USP should be used
with great care, if at all, in
patients with congestive heart failure, severe renal insufficiency,
and in clini